Zai Lab (ZLAB) Financials

$30.38 -1.14 (-3.62%)

Closing price 04/15/2025 04:00 PM Eastern

Extended Trading

$30.00 -0.38 (-1.25%)

As of 04/15/2025 07:03 PM Eastern

Annual Income Statements for Zai Lab

This table shows Zai Lab's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	-18	-38	-50	-139	-195	-269	-704	-443	-335	-257
Consolidated Net Income / (Loss)	-18	-38	-50	-139	-195	-269	-704	-443	-335	-257
Net Income / (Loss) Continuing Operations	-18	-38	-50	-139	-195	-269	-704	-443	-335	-257
Total Pre-Tax Income	-18	-38	-50	-138	-194	-268	-703	-443	-335	-257
Total Operating Income	-16	-39	-51	-142	-203	-302	-700	-404	-367	-282
Total Gross Profit	0.00	0.00	0.00	0.09	9.24	32	92	141	171	251
Total Revenue	0.00	0.00	0.00	0.13	13	49	144	215	267	399
Operating Revenue	-	0.00	0.00	0.13	13	49	144	215	267	399
Total Cost of Revenue	0.00	0.00	0.00	0.04	3.75	17	52	74	96	148
Operating Cost of Revenue	-	0.00	0.00	0.04	3.75	17	52	74	96	148
Total Operating Expenses	16	39	51	142	212	334	792	545	537	533
Selling, General & Admin Expense	2.76	6.38	12	22	70	111	219	259	282	299
Research & Development Expense	14	32	39	120	142	223	573	286	266	235
Other Special Charges / (Income)	-	-	-	-	-	-	-	0.00	-10	0.00
Total Other Income / (Expense), net	-1.67	1.02	1.26	3.28	8.88	34	-3.35	-39	32	25
Interest Expense	-	0.00	0.00	0.04	0.29	0.18	-	0.00	0.00	2.25
Interest & Investment Income	0.01	0.40	0.53	3.26	8.23	5.12	2.19	15	40	37
Other Income / (Expense), net	-1.68	0.61	0.73	0.06	0.94	29	-5.54	-53	-7.84	-9.84
Income Tax Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Gains / (Losses), net	0.00	0.00	-0.25	-0.59	-0.75	-1.12	-1.06	-0.22	0.00	0.00
Basic Earnings per Share	($2.07)	($3.97)	($2.32)	($2.64)	($3.03)	($0.35)	($0.76)	($0.46)	($0.35)	($0.26)
Weighted Average Basic Shares Outstanding	8.69M	9.44M	21.75M	52.61M	64.37M	776.68M	929.92M	958.07M	966.39M	989.48M
Diluted Earnings per Share	($2.07)	($3.97)	($2.32)	($2.64)	($3.03)	($0.35)	($0.76)	($0.46)	($0.35)	($0.26)
Weighted Average Diluted Shares Outstanding	8.69M	9.44M	21.75M	52.61M	64.37M	776.68M	929.92M	958.07M	966.39M	989.48M
Weighted Average Basic & Diluted Shares Outstanding	8.69M	9.44M	21.75M	52.61M	64.37M	77.67M	92.99M	1.72B	1.75B	1.93B

This table shows Zai Lab's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	-161	-62	-49	-121	-69	-95	-53	-80	-42	-82
Consolidated Net Income / (Loss)	-161	-62	-49	-121	-69	-95	-53	-80	-42	-82
Net Income / (Loss) Continuing Operations	-161	-62	-49	-121	-69	-95	-53	-80	-42	-82
Total Pre-Tax Income	-161	-62	-49	-121	-69	-95	-53	-80	-42	-82
Total Operating Income	-129	-97	-70	-90	-84	-124	-70	-76	-68	-68
Total Gross Profit	37	42	41	45	44	41	54	65	65	67
Total Revenue	58	63	63	69	69	66	87	101	102	109
Operating Revenue	58	63	63	69	69	66	87	101	102	109
Total Cost of Revenue	20	21	21	24	25	25	34	35	37	42
Operating Cost of Revenue	20	21	21	24	25	25	34	35	37	42
Total Operating Expenses	166	139	111	135	127	165	124	141	133	135
Selling, General & Admin Expense	67	72	63	68	69	83	69	80	67	83
Research & Development Expense	100	67	48	77	59	82	55	62	66	52
Total Other Income / (Expense), net	-33	36	20	-31	14	29	17	-4.21	26	-14
Interest Expense	-	-	0.00	0.00	0.00	-	0.11	0.49	0.75	0.90
Interest & Investment Income	3.87	9.35	10	10	9.17	10	9.66	9.33	9.03	9.09
Other Income / (Expense), net	-36	26	10	-41	5.25	18	7.29	-13	18	-22
Basic Earnings per Share	($0.17)	($0.06)	($0.05)	($0.13)	($0.07)	($0.10)	($0.05)	($0.08)	($0.04)	($0.09)
Weighted Average Basic Shares Outstanding	959.09M	958.07M	961.44M	964.82M	968.77M	966.39M	973.15M	975.94M	981.69M	989.48M
Diluted Earnings per Share	($0.17)	($0.06)	($0.05)	($0.13)	($0.07)	($0.10)	($0.05)	($0.08)	($0.04)	($0.09)
Weighted Average Diluted Shares Outstanding	959.09M	958.07M	961.44M	964.82M	968.77M	966.39M	973.15M	975.94M	981.69M	989.48M
Weighted Average Basic & Diluted Shares Outstanding	1.72B	1.72B	1.72B	1.73B	1.74B	1.75B	1.75B	1.76B	1.76B	1.93B

This table details how cash moves in and out of Zai Lab's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	6.01	71	146	-167	13	366	522	44	-218	-240
Net Cash From Operating Activities	-11	-32	-32	-98	-191	-216	-549	-368	-198	-215
Net Cash From Continuing Operating Activities	-11	-32	-33	-98	-191	-216	-549	-368	-198	-215
Net Income / (Loss) Continuing Operations	-18	-38	-50	-139	-195	-269	-704	-443	-335	-257
Consolidated Net Income / (Loss)	-18	-38	-50	-139	-195	-269	-704	-443	-335	-257
Depreciation Expense	0.13	0.20	0.55	1.65	3.77	4.64	6.49	8.23	9.03	12
Amortization Expense	0.00	0.00	-0.08	-0.31	-0.31	-0.31	-0.52	-2.60	-3.38	-2.82
Non-Cash Adjustments To Reconcile Net Income	4.72	6.85	9.74	9.59	24	8.62	115	136	91	102
Changes in Operating Assets and Liabilities, net	1.71	-1.69	7.55	31	-23	40	34	-66	40	-68
Net Cash From Investing Activities	-0.74	-2.73	-10	-213	-15	-555	250	420	-11	-375
Net Cash From Continuing Investing Activities	-0.74	-2.73	-10	-213	-15	-555	250	420	-11	-375
Purchase of Property, Plant & Equipment	-0.74	-2.22	-9.10	-10	-6.04	-10	-18	-25	-7.21	-5.66
Acquisitions	0.00	-0.01	-1.92	-2.19	-1.37	-0.54	-31	-0.40	-1.28	-56
Purchase of Investments	0.00	-0.50	0.00	-200	-278	-949	-445	-260	-134	-330
Sale of Property, Plant & Equipment	0.00	0.00	0.08	-	0.00	0.00	0.00	0.00	0.12	0.03
Divestitures	-	-	-	-	-	-	0.00	0.00	10	0.00
Sale and/or Maturity of Investments	-	-	0.50	0.00	278	405	744	705	118	16
Other Investing Activities, net	0.00	0.00	0.00	0.00	-7.84	-	0.00	0.00	3.89	0.00
Net Cash From Financing Activities	18	106	188	144	219	1,132	820	-1.73	-6.43	350
Net Cash From Continuing Financing Activities	18	106	188	144	219	1,132	820	-1.73	-6.43	350
Repayment of Debt	-	-	0.00	0.00	-4.35	-6.53	-	0.00	0.00	-0.98
Repurchase of Common Equity	0.00	0.00	-2.73	-0.69	-0.85	-5.38	-1.84	0.00	0.00	-1.28
Issuance of Debt	-	0.00	0.00	3.64	7.25	-	-	0.00	0.00	132
Issuance of Common Equity	0.00	0.00	160	141	216	1,138	819	0.00	0.00	217
Other Financing Activities, net	0.00	0.00	1.07	0.20	1.06	6.66	3.16	-1.73	-6.43	3.20
Effect of Exchange Rate Changes	-0.07	-0.52	0.65	-0.76	0.09	4.86	1.12	-6.27	-2.62	-0.31
Cash Interest Paid	-	0.00	0.00	0.04	0.29	0.19	-	0.00	0.00	2.02

This table details how cash moves in and out of Zai Lab's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	439	-111	-128	-20	-70	0.67	-39	-21	-14	-166
Net Cash From Operating Activities	-126	-109	-69	-59	-55	-15	-90	-42	-27	-56
Net Cash From Continuing Operating Activities	-126	-109	-69	-59	-55	-15	-90	-42	-27	-56
Net Income / (Loss) Continuing Operations	-161	-62	-49	-121	-69	-95	-53	-80	-42	-82
Consolidated Net Income / (Loss)	-161	-62	-49	-121	-69	-95	-53	-80	-42	-82
Depreciation Expense	2.23	2.13	2.66	2.00	1.92	2.46	3.01	2.94	2.87	3.03
Amortization Expense	-0.66	-0.56	-0.58	-1.13	-0.83	-0.84	-0.14	-0.84	-0.84	-1.00
Non-Cash Adjustments To Reconcile Net Income	61	-1.10	10	54	20	6.64	18	36	5.27	43
Changes in Operating Assets and Liabilities, net	-28	-48	-32	7.04	-7.25	72	-57	0.38	7.54	-19
Net Cash From Investing Activities	568	-4.37	-54	43	-14	14	3.29	-0.85	-30	-348
Net Cash From Continuing Investing Activities	568	-4.37	-54	43	-14	14	3.29	-0.85	-30	-348
Purchase of Property, Plant & Equipment	-6.68	-4.41	-3.51	-1.72	-1.76	-0.22	-0.97	-0.74	-1.34	-2.60
Acquisitions	-0.33	0.04	-0.00	-0.63	-0.03	-0.62	-12	-0.13	-29	-15
Purchase of Investments	-	-	-100	-	-34	-	0.00	-	-	-330
Net Cash From Financing Activities	0.71	-0.20	-3.89	-1.49	-1.45	0.39	48	22	42	238
Net Cash From Continuing Financing Activities	0.71	-0.20	-3.89	-1.49	-1.45	0.39	48	22	42	238
Repayment of Debt	-	-	0.00	-	-	-	-0.70	-	-0.28	-0.00
Issuance of Debt	-	-	0.00	-	-	-	48	22	41	20
Other Financing Activities, net	0.71	-0.20	-3.89	-1.49	-1.45	0.39	0.00	0.04	1.28	1.88
Effect of Exchange Rate Changes	-3.99	2.86	-1.30	-2.41	0.35	0.73	-0.10	-0.03	0.54	-0.71
Cash Interest Paid	-	-	0.00	-	-	-	0.05	0.45	0.67	0.85

This table presents Zai Lab's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	89	250	302	355	1,298	1,610	1,220	1,036	1,186
Total Current Assets	84	231	269	292	1,216	1,501	1,124	940	1,050
Cash & Equivalents	84	230	63	76	442	964	1,008	790	450
Restricted Cash	-	-	-	-	-	-	-	0.00	100
Short-Term Investments	-	0.00	200	200	745	445	0.00	16	330
Note & Lease Receivable	-	-	-	-	0.00	7.34	8.61	6.13	4.23
Accounts Receivable	-	0.00	0.09	3.79	5.17	47	40	59	85
Inventories, net	-	0.00	0.00	6.01	13	19	32	45	40
Prepaid Expenses	0.14	0.95	5.75	6.74	11	18	36	23	42
Plant, Property, & Equipment, net	1.25	12	20	21	29	43	58	54	48
Total Noncurrent Assets	3.57	7.17	12	41	52	66	38	43	87
Long-Term Investments	0.50	1.65	3.15	2.40	1.28	16	6.43	9.22	3.12
Intangible Assets	0.01	0.02	0.32	1.15	1.53	1.85	1.51	13	56
Noncurrent Deferred & Refundable Income Taxes	1.38	5.06	8.04	14	22	24	-	0.00	1.35
Other Noncurrent Operating Assets	1.69	0.43	0.83	24	27	25	30	20	27
Total Liabilities & Shareholders' Equity	89	250	302	355	1,298	1,610	1,220	1,036	1,186
Total Liabilities	5.95	14	51	60	128	230	175	240	345
Total Current Liabilities	5.17	12	49	47	98	193	140	203	299
Short-Term Debt	-	0.00	3.64	6.45	-	-	-	0.00	132
Accounts Payable	0.52	8.97	37	23	63	126	66	113	101
Other Current Liabilities	4.65	3.10	7.77	18	35	67	74	90	67
Total Noncurrent Liabilities	0.78	2.39	2.06	14	30	37	35	37	45
Other Noncurrent Operating Liabilities	-	-	-	14	13	37	35	37	45
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-52	235	251	295	1,169	1,380	1,046	796	841
Total Preferred & Common Equity	-52	235	251	295	1,169	1,380	1,046	796	841
Total Common Equity	-52	235	251	295	1,169	1,380	1,046	796	841
Common Stock	9.31	345	498	735	1,897	2,826	2,893	2,975	3,264
Retained Earnings	-60	-111	-250	-445	-714	-1,418	-1,861	-2,196	-2,453
Treasury Stock	-	-	-	-	0.00	-4.28	-12	-21	-21
Accumulated Other Comprehensive Income / (Loss)	-0.70	0.45	2.66	4.62	-15	-24	26	38	51

This table presents Zai Lab's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	1,299	1,170	1,106	1,044	988	987	985
Total Current Assets	1,210	1,072	1,018	960	889	870	861
Cash & Equivalents	1,119	880	859	789	651	630	616
Restricted Cash	-	-	-	-	100	100	100
Short-Term Investments	0.00	51	16	32	0.00	0.00	0.00
Note & Lease Receivable	10	17	21	24	15	8.10	19
Accounts Receivable	28	43	47	42	60	70	50
Inventories, net	29	38	36	44	38	42	40
Prepaid Expenses	22	43	38	30	24	20	36
Plant, Property, & Equipment, net	51	58	56	55	52	51	51
Total Noncurrent Assets	38	39	32	29	47	67	74
Long-Term Investments	3.32	6.87	5.13	4.47	14	4.07	3.15
Intangible Assets	1.54	1.48	1.69	1.57	12	44	52
Noncurrent Deferred & Refundable Income Taxes	0.01	-	-	-	-	-	1.24
Other Noncurrent Operating Assets	33	31	26	23	21	19	18
Total Liabilities & Shareholders' Equity	1,299	1,170	1,106	1,044	988	987	985
Total Liabilities	193	169	174	163	226	283	318
Total Current Liabilities	156	125	133	125	192	252	286
Short-Term Debt	-	-	-	-	48	70	113
Accounts Payable	90	66	67	55	88	127	121
Other Current Liabilities	65	58	66	70	56	54	53
Total Noncurrent Liabilities	37	44	41	38	34	31	31
Noncurrent Deferred Revenue	23	-	-	28	-	-	25
Other Noncurrent Operating Liabilities	14	44	41	10	34	31	6.44
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,106	1,001	932	881	762	704	668
Total Preferred & Common Equity	1,106	1,001	932	881	762	704	668
Total Common Equity	1,106	1,001	932	881	762	704	668
Common Stock	2,877	2,911	2,932	2,954	2,993	3,012	3,032
Retained Earnings	-1,800	-1,911	-2,031	-2,101	-2,249	-2,330	-2,371
Treasury Stock	-11	-17	-21	-21	-21	-21	-21
Accumulated Other Comprehensive Income / (Loss)	40	17	52	48	39	43	28

This table displays calculated financial ratios and metrics derived from Zai Lab's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	0.00%	9,965.89%	277.04%	194.77%	49.01%	24.03%	49.59%
EBITDA Growth	0.00%	-110.70%	-33.07%	-179.67%	-41.63%	-35.01%	-160.67%	35.39%	18.42%	23.28%
EBIT Growth	0.00%	-110.33%	-67.23%	-179.72%	-42.73%	-34.84%	-158.72%	35.14%	18.19%	22.02%
NOPAT Growth	0.00%	-135.66%	-33.38%	-175.86%	-43.33%	-48.53%	-131.96%	42.24%	9.34%	23.04%
Net Income Growth	0.00%	-108.15%	-68.63%	-176.03%	-40.26%	-37.85%	-161.98%	37.08%	24.51%	23.17%
EPS Growth	0.00%	-91.79%	41.56%	-13.79%	-29.55%	88.45%	-117.14%	39.47%	23.91%	25.71%
Operating Cash Flow Growth	0.00%	-180.49%	-1.30%	-201.35%	-95.83%	-13.11%	-154.21%	33.06%	46.09%	-8.42%
Free Cash Flow Firm Growth	0.00%	0.00%	-124.43%	-102.41%	-111.29%	3.96%	-173.35%	22.74%	42.44%	-48.71%
Invested Capital Growth	0.00%	0.00%	358.51%	-403.80%	294.24%	-182.20%	-138.97%	168.59%	-163.70%	559.40%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	25.23%	9.37%	1.23%	12.15%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-23.82%	23.80%	-10.34%	5.44%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-23.63%	23.58%	-10.19%	5.15%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-21.51%	23.16%	-7.85%	16.58%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-23.77%	25.29%	-11.18%	5.07%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	71.96%	-112.17%	-12.90%	3.70%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-24.66%	10.62%	32.26%	-23.48%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-1.21%	33.64%	-26.77%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-1,534.37%	281.37%	-134.85%	46.24%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	0.00%	0.00%	0.00%	66.67%	142.26%	65.82%	63.80%	65.58%	64.08%	62.94%
EBITDA Margin	0.00%	0.00%	0.00%	-108,814.73%	-1,531.03%	-548.22%	-484.81%	-210.20%	-138.26%	-70.91%
Operating Margin	0.00%	0.00%	0.00%	-109,897.67%	-3,129.70%	-616.45%	-485.10%	-188.04%	-137.44%	-70.71%
EBIT Margin	0.00%	0.00%	0.00%	-109,851.94%	-3,115.26%	-557.06%	-488.94%	-212.82%	-140.38%	-73.17%
Profit (Net Income) Margin	0.00%	0.00%	0.00%	-107,810.08%	-1,502.28%	-549.26%	-488.16%	-206.14%	-125.46%	-64.44%
Tax Burden Percent	100.00%	100.00%	301.50%	100.42%	200.77%	100.42%	100.15%	100.05%	100.00%	100.00%
Interest Burden Percent	99.97%	98.94%	197.92%	97.73%	192.15%	98.19%	99.69%	96.81%	89.37%	88.06%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	-2,573.96%	-10,422.33%	0.00%	0.00%	-4,606.43%	-562.03%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	-2,554.20%	-10,414.44%	0.00%	0.00%	-4,597.90%	-554.42%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	5,004.95%	10,385.60%	0.00%	0.00%	4,570.09%	530.62%
Return on Equity (ROE)	0.00%	-45.22%	-63.35%	-57.20%	-71.49%	-36.74%	-55.27%	-36.55%	-36.34%	-31.41%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	-1,070.53%	0.00%	-775.88%	0.00%	0.00%	-1,167.96%	0.00%	-341.61%
Operating Return on Assets (OROA)	0.00%	0.00%	0.00%	-51.38%	-123.11%	-33.00%	-48.54%	-32.34%	-33.19%	-26.28%
Return on Assets (ROA)	0.00%	0.00%	0.00%	-50.42%	-118.74%	-32.54%	-48.46%	-31.33%	-29.66%	-23.14%
Return on Common Equity (ROCE)	0.00%	28.10%	-36.57%	-57.20%	-142.97%	-36.74%	-55.27%	-36.55%	-36.34%	-31.41%
Return on Equity Simple (ROE_SIMPLE)	0.00%	72.77%	-42.85%	-55.39%	-132.40%	-23.00%	-51.05%	-42.40%	-42.03%	-30.57%
Net Operating Profit after Tax (NOPAT)	-11	-27	-36	-99	-142	-211	-490	-283	-257	-197
NOPAT Margin	0.00%	0.00%	0.00%	-76,928.37%	-1,095.40%	-431.51%	-339.57%	-131.63%	-96.21%	-49.50%
Net Nonoperating Expense Percent (NNEP)	0.00%	-24.97%	-18.25%	-16.12%	-19.76%	-7.90%	-16.41%	-13.14%	-8.52%	-7.61%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-27.07%	-32.23%	-20.30%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	33.33%	57.74%	34.18%	36.20%	34.42%	35.92%	37.06%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	16,725.58%	1,081.42%	227.36%	151.64%	120.43%	105.58%	74.87%
R&D to Revenue	0.00%	0.00%	0.00%	93,238.76%	1,095.27%	454.90%	397.27%	133.19%	99.68%	58.77%
Operating Expenses to Revenue	0.00%	0.00%	0.00%	109,964.34%	1,635.98%	682.26%	548.91%	253.62%	201.51%	133.65%
Earnings before Interest and Taxes (EBIT)	-18	-38	-51	-142	-202	-273	-706	-458	-374	-292
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-18	-38	-50	-140	-199	-268	-700	-452	-369	-283
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	1.96	4.68	17.89	7.91	7.53	50.58	59.83	54.79
Price to Tangible Book Value (P/TBV)	0.00	0.00	1.96	4.68	17.96	7.92	7.54	50.65	60.85	58.70
Price to Revenue (P/Rev)	0.00	0.00	0.00	9,100.06	393.08	189.02	71.99	245.93	178.58	115.47
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	207.51	0.00	0.00	1,689.94	0.00	504.51
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	7,062.78	165.97	164.75	62.12	241.22	175.52	113.58
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.01	0.04	0.00	0.00	0.00	0.00	0.16
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	0.00	-1.02	-1.98	-1.02	-1.90	-1.00	-1.02	-1.01	-0.99	-0.96
Leverage Ratio	0.00	1.07	2.13	1.13	2.41	1.13	1.14	1.17	1.23	1.36
Compound Leverage Factor	0.00	1.06	2.11	1.11	2.31	1.11	1.14	1.13	1.10	1.20
Debt to Total Capital	0.00%	0.00%	0.00%	1.43%	4.28%	0.00%	0.00%	0.00%	0.00%	13.54%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	1.43%	4.28%	0.00%	0.00%	0.00%	0.00%	13.54%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	162.14%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	-62.14%	200.00%	98.57%	195.72%	100.00%	100.00%	100.00%	100.00%	86.46%
Debt to EBITDA	0.00	0.00	0.00	-0.03	-0.06	0.00	0.00	0.00	0.00	-0.47
Net Debt to EBITDA	0.00	0.00	0.00	1.87	2.74	0.00	0.00	0.00	0.00	2.65
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	-0.04	-0.09	0.00	0.00	0.00	0.00	-0.67
Net Debt to NOPAT	0.00	0.00	0.00	2.65	3.82	0.00	0.00	0.00	0.00	3.80
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	0.00	0.00	18.92	12.01	46.75	42.89	25.49	179.57	115.94	77.54
Noncontrolling Interest Sharing Ratio	0.00%	162.14%	84.56%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	16.25	38.22	5.51	12.54	12.40	7.78	8.04	4.63	3.51
Quick Ratio	0.00	16.23	38.06	5.39	12.00	12.16	7.59	7.56	4.29	2.90
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-25	-41	-84	-177	-170	-464	-358	-206	-307
Operating Cash Flow to CapEx	-1,552.52%	-1,446.03%	-717.73%	-973.92%	-6,330.11%	-2,132.82%	-3,002.57%	-1,495.39%	-2,795.18%	-3,817.86%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	-2,091.23	-1,206.45	-937.87	0.00	0.00	0.00	-136.14
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	-2,438.45	-651.91	-1,193.67	0.00	0.00	0.00	-95.33
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	-2,688.83	-1,345.02	-1,249.64	0.00	0.00	0.00	-97.82
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.00	0.00	0.04	0.06	0.10	0.15	0.24	0.36
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	13.38	10.93	5.48	4.92	5.38	5.53
Inventory Turnover	0.00	0.00	0.00	0.00	1.25	1.75	3.26	2.93	2.51	3.49
Fixed Asset Turnover	0.00	0.00	0.00	0.01	0.62	1.94	3.99	4.26	4.78	7.85
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.12	0.39	0.55	0.77	1.07	1.38
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	54.55	33.39	66.57	74.21	67.85	66.04
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	585.03	208.81	112.13	124.69	145.61	104.55
Days Payable Outstanding (DPO)	0.00	0.00	0.00	196,928.90	5,850.51	930.18	659.60	473.74	340.87	264.01
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	-196,928.90	-2,578.20	-687.98	-480.90	-274.84	-127.41	-93.42
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	-1.49	3.86	-12	23	-19	-45	31	-20	90
Invested Capital Turnover	0.00	0.00	0.00	-0.03	2.35	24.15	-4.55	-30.60	47.88	11.36
Increase / (Decrease) in Invested Capital	0.00	-1.49	5.35	-16	35	-42	-26	75	-50	109
Enterprise Value (EV)	0.00	0.00	231	911	2,155	8,066	8,965	51,871	46,815	45,319
Market Capitalization	0.00	0.00	462	1,174	5,271	9,254	10,389	52,886	47,630	46,070
Book Value per Share	$0.00	($5.46)	$10.81	$4.97	$5.05	$17.10	$8.35	$0.61	$0.82	$0.48
Tangible Book Value per Share	$0.00	($5.46)	$10.81	$4.96	$5.03	$17.08	$8.34	$0.61	$0.81	$0.45
Total Capital	0.00	83	235	255	301	1,169	1,380	1,046	796	973
Total Debt	0.00	0.00	0.00	3.64	6.45	0.00	0.00	0.00	0.00	132
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	0.00	-84	-231	-263	-272	-1,188	-1,425	-1,015	-816	-751
Capital Expenditures (CapEx)	0.74	2.22	9.02	10	6.04	10	18	25	7.09	5.63
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-5.03	-11	-39	-24	-69	-101	-24	-70	3.14
Debt-free Net Working Capital (DFNWC)	0.00	79	219	224	252	1,118	1,308	984	737	883
Net Working Capital (NWC)	0.00	79	219	220	246	1,118	1,308	984	737	751
Net Nonoperating Expense (NNE)	6.58	11	14	40	53	58	214	160	78	60
Net Nonoperating Obligations (NNO)	0.00	-84	-231	-263	-272	-1,188	-1,425	-1,015	-816	-751
Total Depreciation and Amortization (D&A)	0.13	0.20	0.47	1.34	3.45	4.33	5.97	5.63	5.65	9.04
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	-30,508.53%	-182.16%	-140.53%	-70.07%	-11.15%	-26.21%	0.79%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	173,601.55%	3,885.70%	2,283.58%	906.36%	457.82%	276.15%	221.26%
Net Working Capital to Revenue	0.00%	0.00%	0.00%	170,777.52%	3,786.35%	2,283.58%	906.36%	457.82%	276.15%	188.25%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($2.32)	($2.64)	($3.03)	($3.46)	($7.58)	($0.46)	($0.35)	($0.26)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	50.56M	58.36M	68.38M	88.59M	167.45M	958.07M	966.39M	989.48M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($2.32)	($2.64)	($3.03)	($3.46)	($7.58)	($0.46)	($0.35)	($0.26)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	50.56M	58.36M	68.38M	88.59M	167.45M	958.07M	966.39M	989.48M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	($2.32)	($2.64)	($3.03)	($3.46)	($7.58)	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	21.75M	52.61M	64.37M	77.67M	92.99M	1.72B	1.75B	1.93B
Normalized Net Operating Profit after Tax (NOPAT)	-11	-27	-36	-99	-142	-211	-490	-283	-264	-197
Normalized NOPAT Margin	0.00%	0.00%	0.00%	-76,928.37%	-2,190.79%	-431.51%	-339.57%	-131.63%	-98.83%	-49.50%
Pre Tax Income Margin	0.00%	0.00%	0.00%	-107,355.04%	-2,992.98%	-546.97%	-487.43%	-206.04%	-125.46%	-64.44%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	-3,542.73	-690.30	-1,506.77	0.00	0.00	0.00	-129.53
NOPAT to Interest Expense	0.00	0.00	0.00	-2,480.94	-485.45	-1,167.19	0.00	0.00	0.00	-87.61
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	-3,793.10	-1,421.80	-1,562.73	0.00	0.00	0.00	-132.02
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	-2,731.32	-506.05	-1,223.15	0.00	0.00	0.00	-90.11
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	-8.13%	-0.50%	-0.88%	-2.00%	-0.26%	0.00%	0.00%	-0.50%

This table displays calculated financial ratios and metrics derived from Zai Lab's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	33.49%	41.72%	34.40%	42.94%	20.31%	5.16%	38.78%	45.95%	47.72%	65.68%
EBITDA Growth	14.16%	67.00%	29.31%	5.66%	52.76%	-49.69%	-4.96%	33.13%	37.95%	15.63%
EBIT Growth	14.73%	66.51%	27.91%	5.84%	52.55%	-48.68%	-6.13%	31.97%	36.22%	15.00%
NOPAT Growth	-54.54%	55.61%	12.84%	9.33%	35.01%	-27.43%	-1.13%	15.01%	18.81%	45.24%
Net Income Growth	-67.19%	70.84%	40.35%	12.35%	57.10%	-54.49%	-8.80%	33.60%	39.74%	14.40%
EPS Growth	-70.00%	-101.44%	44.44%	7.14%	58.82%	-66.67%	0.00%	38.46%	42.86%	10.00%
Operating Cash Flow Growth	21.48%	28.56%	20.48%	-30.74%	56.25%	86.35%	-30.05%	28.16%	51.47%	-273.86%
Free Cash Flow Firm Growth	-30.91%	-12.66%	-158.95%	24.41%	-76.66%	74.55%	75.43%	74.64%	59.85%	-329.41%
Invested Capital Growth	-1,136.16%	168.59%	605.06%	212.35%	431.54%	-163.70%	-28.80%	-23.18%	9.48%	559.40%
Revenue Q/Q Growth	19.44%	8.79%	0.31%	9.66%	0.53%	-4.91%	32.38%	15.32%	1.75%	6.65%
EBITDA Q/Q Growth	-18.54%	57.46%	17.61%	-127.09%	40.64%	-34.79%	42.23%	-44.67%	44.92%	-83.29%
EBIT Q/Q Growth	-18.66%	56.92%	16.51%	-120.60%	40.20%	-34.99%	40.40%	-41.42%	43.94%	-79.90%
NOPAT Q/Q Growth	-30.26%	24.33%	28.54%	-28.74%	6.63%	-48.35%	43.29%	-8.19%	10.79%	-0.06%
Net Income Q/Q Growth	-16.86%	61.68%	20.44%	-146.00%	42.80%	-38.00%	43.97%	-50.13%	48.09%	-96.02%
EPS Q/Q Growth	-21.43%	64.71%	16.67%	-160.00%	46.15%	-42.86%	50.00%	-60.00%	50.00%	-125.00%
Operating Cash Flow Q/Q Growth	-181.34%	13.48%	36.60%	15.28%	5.84%	73.01%	-504.05%	53.20%	36.40%	-107.93%
Free Cash Flow Firm Q/Q Growth	65.25%	-92.80%	12.71%	-29.23%	18.78%	72.22%	15.72%	-33.37%	-28.60%	-197.09%
Invested Capital Q/Q Growth	63.81%	281.37%	108.43%	-17.89%	6.81%	-134.85%	332.97%	-11.41%	52.21%	46.24%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	65.17%	66.58%	66.02%	65.49%	63.20%	61.66%	61.42%	64.94%	63.90%	61.41%
EBITDA Margin	-284.13%	-111.10%	-91.25%	-188.96%	-111.57%	-158.15%	-69.01%	-86.58%	-46.86%	-80.53%
Operating Margin	-223.47%	-155.42%	-110.71%	-129.97%	-120.72%	-188.33%	-80.68%	-75.68%	-66.35%	-62.25%
EBIT Margin	-286.86%	-113.60%	-94.55%	-190.21%	-113.14%	-160.61%	-72.31%	-88.67%	-48.85%	-82.39%
Profit (Net Income) Margin	-280.14%	-98.67%	-78.26%	-175.56%	-99.89%	-144.96%	-61.36%	-79.87%	-40.75%	-74.89%
Tax Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	97.65%	86.86%	82.77%	92.30%	88.29%	90.26%	84.85%	90.08%	83.42%	90.89%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	-698.14%	-7,933.58%	-1,136.45%	-6,312.27%	-300.16%	-368.11%	-281.16%	-494.77%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	-698.10%	-7,928.13%	-1,135.36%	-6,311.33%	-299.64%	-364.61%	-281.98%	-490.41%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	682.59%	7,906.78%	1,112.97%	6,273.15%	281.03%	343.92%	260.58%	469.35%
Return on Equity (ROE)	-44.05%	-36.55%	-15.55%	-26.80%	-23.49%	-39.12%	-19.13%	-24.20%	-20.59%	-25.41%
Cash Return on Invested Capital (CROIC)	0.00%	-1,167.96%	-551.02%	-701.90%	-554.21%	0.00%	-435.92%	-507.22%	-411.91%	-341.61%
Operating Return on Assets (OROA)	-37.27%	-17.26%	-16.36%	-37.93%	-25.46%	-37.97%	-19.50%	-27.33%	-17.13%	-29.59%
Return on Assets (ROA)	-36.40%	-14.99%	-13.54%	-35.01%	-22.47%	-34.27%	-16.55%	-24.62%	-14.29%	-26.89%
Return on Common Equity (ROCE)	-44.11%	-36.55%	-15.55%	-26.80%	-23.49%	-39.12%	-19.13%	-24.20%	-20.59%	-25.41%
Return on Equity Simple (ROE_SIMPLE)	-53.65%	0.00%	-40.95%	-42.15%	-34.16%	0.00%	-44.47%	-42.37%	-40.57%	0.00%
Net Operating Profit after Tax (NOPAT)	-90	-68	-49	-63	-58	-87	-49	-53	-47	-48
NOPAT Margin	-156.43%	-108.80%	-77.50%	-90.98%	-84.50%	-131.83%	-56.47%	-52.98%	-46.45%	-43.57%
Net Nonoperating Expense Percent (NNEP)	-3.31%	0.52%	-0.04%	-5.45%	-1.09%	-0.94%	-0.51%	-3.50%	0.81%	-4.36%
Return On Investment Capital (ROIC_SIMPLE)	-	-6.51%	-	-	-	-10.90%	-	-	-	-4.89%
Cost of Revenue to Revenue	34.83%	33.42%	33.98%	34.51%	36.80%	38.34%	38.58%	35.06%	36.10%	38.59%
SG&A Expenses to Revenue	115.67%	115.05%	99.54%	98.63%	99.02%	125.51%	79.40%	79.31%	65.73%	75.75%
R&D to Revenue	172.96%	106.94%	77.19%	111.35%	84.89%	124.48%	62.70%	61.32%	64.52%	47.91%
Operating Expenses to Revenue	288.63%	222.00%	176.73%	195.46%	183.91%	250.00%	142.10%	140.63%	130.25%	123.65%
Earnings before Interest and Taxes (EBIT)	-165	-71	-59	-131	-78	-106	-63	-89	-50	-90
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-163	-70	-57	-130	-77	-104	-60	-87	-48	-88
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	53.27	50.58	57.22	51.24	47.84	59.83	36.79	43.07	63.57	54.79
Price to Tangible Book Value (P/TBV)	53.35	50.65	57.31	51.33	47.93	60.85	37.40	45.95	68.90	58.70
Price to Revenue (P/Rev)	299.65	245.93	247.91	189.71	159.96	178.58	96.33	93.99	119.31	115.47
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	1,689.94	880.93	892.61	736.51	0.00	599.77	735.13	681.11	504.51
Enterprise Value to Revenue (EV/Rev)	293.94	241.22	243.86	186.22	156.83	175.52	93.87	91.93	117.60	113.58
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.06	0.10	0.17	0.16
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-1.60	-1.01	-0.98	-1.00	-0.98	-0.99	-0.94	-0.94	-0.92	-0.96
Leverage Ratio	1.12	1.17	1.16	1.18	1.18	1.23	1.22	1.28	1.31	1.36
Compound Leverage Factor	1.10	1.01	0.96	1.09	1.04	1.11	1.04	1.15	1.09	1.23
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	5.96%	9.08%	14.47%	13.54%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	5.96%	9.08%	14.47%	13.54%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	94.04%	90.92%	85.53%	86.46%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	-0.13	-0.21	-0.38	-0.47
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	1.93	2.02	2.03	2.65
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	-0.19	-0.28	-0.48	-0.67
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	2.79	2.68	2.56	3.80
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	182.26	180.61	202.34	162.89	153.57	116.80	72.09	61.74	77.69	78.11
Noncontrolling Interest Sharing Ratio	-0.13%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	7.78	8.04	8.61	7.63	7.68	4.63	4.63	3.46	3.01	3.51
Quick Ratio	7.44	7.56	7.96	7.07	7.09	4.29	3.78	2.81	2.39	2.90
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-74	-144	-125	-162	-132	-37	-31	-41	-53	-157
Operating Cash Flow to CapEx	-1,889.93%	-2,476.59%	-2,037.25%	-3,410.92%	-3,165.64%	-6,719.37%	-9,251.13%	-5,923.17%	-1,998.58%	-2,144.96%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	-272.51	-83.48	-70.89	-173.57
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	-797.40	-85.72	-36.00	-61.69
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	-806.02	-87.16	-37.80	-64.57
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.13	0.15	0.17	0.20	0.23	0.24	0.27	0.31	0.35	0.36
Accounts Receivable Turnover	8.07	4.92	6.02	6.77	7.60	5.38	5.61	5.52	7.77	5.53
Inventory Turnover	3.59	2.93	2.72	2.88	2.49	2.51	2.84	3.06	3.13	3.49
Fixed Asset Turnover	4.49	4.26	4.46	4.90	4.98	4.78	5.26	6.03	6.71	7.85
Accounts Payable Turnover	1.06	0.77	0.97	0.98	1.26	1.07	1.40	1.23	1.49	1.38
Days Sales Outstanding (DSO)	45.25	74.21	60.60	53.88	48.02	67.85	65.06	66.12	46.97	66.04
Days Inventory Outstanding (DIO)	101.56	124.69	134.38	126.57	146.31	145.61	128.74	119.36	116.71	104.55
Days Payable Outstanding (DPO)	345.29	473.74	376.67	372.08	289.46	340.87	260.81	296.68	244.72	264.01
Cash Conversion Cycle (CCC)	-198.47	-274.84	-181.70	-191.63	-95.13	-127.41	-67.01	-111.20	-81.04	-93.42
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	-17	31	64	53	56	-20	46	40	61	90
Invested Capital Turnover	-21.50	-30.60	9.01	87.20	13.45	47.88	5.32	6.95	6.05	11.36
Increase / (Decrease) in Invested Capital	-16	75	77	99	73	-50	-18	-12	5.32	109
Enterprise Value (EV)	57,792	51,871	56,359	46,890	41,324	46,815	27,321	29,667	41,836	45,319
Market Capitalization	58,915	52,886	57,296	47,769	42,148	47,630	28,038	30,331	42,443	46,070
Book Value per Share	$0.64	$0.61	$0.58	$0.54	$0.51	$0.82	$0.44	$0.40	$0.38	$0.48
Tangible Book Value per Share	$0.64	$0.61	$0.58	$0.54	$0.51	$0.81	$0.43	$0.38	$0.35	$0.45
Total Capital	1,106	1,046	1,001	932	881	796	810	774	781	973
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	48	70	113	132
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-1,123	-1,015	-937	-880	-825	-816	-717	-664	-606	-751
Capital Expenditures (CapEx)	6.68	4.41	3.40	1.72	1.75	0.22	0.97	0.71	1.34	2.60
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-65	-24	17	9.50	14	-70	-5.97	-42	-29	3.14
Debt-free Net Working Capital (DFNWC)	1,054	984	948	884	835	737	745	689	687	883
Net Working Capital (NWC)	1,054	984	948	884	835	737	697	618	574	751
Net Nonoperating Expense (NNE)	71	-6.34	0.48	58	11	8.64	4.25	27	-5.83	34
Net Nonoperating Obligations (NNO)	-1,123	-1,015	-937	-880	-825	-816	-717	-664	-606	-751
Total Depreciation and Amortization (D&A)	1.57	1.57	2.08	0.86	1.09	1.62	2.87	2.10	2.03	2.03
Debt-free, Cash-free Net Working Capital to Revenue	-33.16%	-11.15%	7.50%	3.77%	5.48%	-26.21%	-2.05%	-12.87%	-8.11%	0.79%
Debt-free Net Working Capital to Revenue	536.23%	457.82%	410.08%	351.13%	316.84%	276.15%	255.89%	213.35%	193.18%	221.26%
Net Working Capital to Revenue	536.23%	457.82%	410.08%	351.13%	316.84%	276.15%	239.30%	191.57%	161.42%	188.25%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.17)	($0.06)	($0.05)	($0.13)	($0.07)	($0.10)	($0.05)	($0.08)	($0.04)	($0.09)
Adjusted Weighted Average Basic Shares Outstanding	959.09M	958.07M	961.44M	964.82M	968.77M	966.39M	973.15M	975.94M	981.69M	989.48M
Adjusted Diluted Earnings per Share	($0.17)	($0.06)	($0.05)	($0.13)	($0.07)	($0.10)	($0.05)	($0.08)	($0.04)	($0.09)
Adjusted Weighted Average Diluted Shares Outstanding	959.09M	958.07M	961.44M	964.82M	968.77M	966.39M	973.15M	975.94M	981.69M	989.48M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	1.72B	1.72B	1.72B	1.73B	1.74B	1.75B	1.75B	1.76B	1.76B	1.93B
Normalized Net Operating Profit after Tax (NOPAT)	-90	-68	-49	-70	-58	-87	-49	-53	-47	-48
Normalized NOPAT Margin	-156.43%	-108.80%	-77.50%	-101.14%	-84.50%	-131.83%	-56.47%	-52.98%	-46.45%	-43.57%
Pre Tax Income Margin	-280.14%	-98.67%	-78.26%	-175.56%	-99.89%	-144.96%	-61.36%	-79.87%	-40.75%	-74.89%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	-557.66	-181.13	-67.05	-99.41
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	-435.54	-108.22	-63.75	-52.57
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	-566.28	-182.58	-68.86	-102.29
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	-444.16	-109.67	-65.56	-55.45
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.50%

Frequently Asked Questions About Zai Lab's Financials

When does Zai Lab's financial year end?

According to the most recent income statement we have on file, Zai Lab's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Zai Lab's net income changed over the last 9 years?

Zai Lab's net income appears to be on an upward trend, with a most recent value of -$257.10 million in 2024, rising from -$18.02 million in 2015. The previous period was -$334.62 million in 2023.

What is Zai Lab's operating income?

Zai Lab's total operating income in 2024 was -$282.12 million, based on the following breakdown:

Total Gross Profit: $251.13 million
Total Operating Expenses: $533.25 million

How has Zai Lab revenue changed over the last 9 years?

Over the last 9 years, Zai Lab's total revenue changed from $0.00 in 2015 to $398.99 million in 2024, a change of 39,898,800,000.0%.

How much debt does Zai Lab have?

Zai Lab's total liabilities were at $344.86 million at the end of 2024, a 43.6% increase from 2023, and a 5,694.0% increase since 2016.

How much cash does Zai Lab have?

In the past 8 years, Zai Lab's cash and equivalents has ranged from $62.95 million in 2018 to $1.01 billion in 2022, and is currently $449.67 million as of their latest financial filing in 2024.

How has Zai Lab's book value per share changed over the last 9 years?

Over the last 9 years, Zai Lab's book value per share changed from 0.00 in 2015 to 0.48 in 2024, a change of 47.8%.

Remove Ads

Related Companies

This page (NASDAQ:ZLAB) was last updated on 4/16/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Zai Lab (ZLAB) Financials

Frequently Asked Questions About Zai Lab's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Zai Lab (ZLAB) Financials

Annual Income Statements for Zai Lab

Quarterly Income Statements for Zai Lab

Annual Cash Flow Statements for Zai Lab

Quarterly Cash Flow Statements for Zai Lab

Annual Balance Sheets for Zai Lab

Quarterly Balance Sheets for Zai Lab

Annual Metrics and Ratios for Zai Lab

Quarterly Metrics and Ratios for Zai Lab

Frequently Asked Questions About Zai Lab's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools